迪安诊断股价涨5.31%，永赢基金旗下1只基金位居十大流通股东，持有308.75万股浮盈赚取379.76万元

Group 1 - The core viewpoint of the news is that Dian Diagnostics has seen a stock price increase of 5.31%, reaching 24.41 yuan per share, with a trading volume of 597 million yuan and a turnover rate of 4.98%, resulting in a total market capitalization of 15.256 billion yuan [1] - Dian Diagnostics, established on September 5, 2001, and listed on July 19, 2011, provides medical diagnostic services primarily to various healthcare institutions, with its main business revenue composition being 65.34% from channel products and 34.66% from diagnostic services [1] Group 2 - Among the top ten circulating shareholders of Dian Diagnostics, a fund under Yongying Fund ranks first, while the Medical Device ETF (159883) entered the top ten shareholders in the third quarter, holding 3.0875 million shares, which is 0.62% of the circulating shares, with an estimated floating profit of approximately 3.7976 million yuan [2] - The Medical Device ETF (159883) was established on April 22, 2021, with a current scale of 3.677 billion yuan, showing a year-to-date return of 2.54% and a one-year return of 7.87%, but has experienced a loss of 49.97% since its inception [2]